Skip to main content

Bank of New York Mellon Corp

Bank

Position in ASND — Ascendis Pharma A/S

CIK 1390777 NEW YORK, NY

Position in ASND

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$52,304,827
+$10,807,260 QoQ
Shares Held
228,675
+17.5% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 77.51874931671587.ToString("F0")% Shared 0.ToString("F0")% None 22.481250683284138.ToString("F0")%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,202,987,460 across 269 Biotechnology names. ASND ranks #19 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ASND

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $52,304,827 228,675
2025-12-31 $41,497,567 194,605
2025-09-30 $41,610,532 209,298
2025-06-30 $20,300,518 117,616
2025-03-31 $13,904,112 89,209
2024-12-31 $13,545,623 98,392
2024-09-30 $15,710,096 105,218
2024-06-30 $15,089,215 110,641
2024-03-31 $22,818,199 150,944
2023-12-31 $26,848,630 213,169
2023-09-30 $21,795,829 232,762
2023-06-30 $28,202,640 315,996
2023-03-31 $26,313,822 245,419
2022-12-31 $30,611,882 250,650
2022-09-30 $26,996,394 261,441
2022-06-30 $25,094,176 269,946
2022-03-31 $33,957,408 289,344
2021-12-31 $32,293,385 240,046
2021-09-30 $38,593,576 242,133
2021-06-30 $34,593,700 262,970
2021-03-31 $33,871,465 262,814
2020-09-30 $23,486,421 152,193
2020-06-30 $20,267,769 137,037
2020-03-31 $14,325,903 127,217